IL-17 is known to be a cytokine mainly secreted from T h 17 cells, which well associate with autoimmune inflammatory responses. In the generation of T h 17 cells, RORc and RORa have pivotal roles in controlling the transcription of Il17. We speculated additional regulation in Il17a transcription and randomly screened a 6344 clone cDNA library to identify specific modulators for Il17a promoter activity. After the screen, the E3 ubiquitin ligases SIAH1 and SIAH2 were investigated further and confirmed to increase Il17a promoter activity in a T-cell line and to promote T h 17 development ex vivo. This enhancement was a consequence of enhanced expression of hypoxia-inducible factor-1α (HIF-1α) protein, which is reported to directly regulate expression of Il17a and Rorgt at the transcriptional level. In the absence of HIF-1α, both ubiquitin ligases had little effect on T h 17 cell differentiation. These results suggest that the SIAH1 and SIAH2 play a pivotal role to promote T h 17 cell differentiation through maintaining the stability of HIF-1α protein.
Introduction
T h 17 cells are the effector T h cell subset thought to contribute to anti-microbial immunity at epithelial or mucosal barriers. T h 17 cells are named based on the expression of the cytokine IL-17A, but cells also produce various other cytokines including IL-17F, IL-21, IL-22, GM-CSF, TNF-α and IL-6 (1-3). T h 17 cells play a pathologic role in the induction of several autoimmune diseases, including psoriasis and psoriatic arthritis (4) . In both human and mouse, the T h 17/Treg balance plays a critical role in the disease situation. T h 17 and Treg cells share a common requirement for TGF-β in their induction despite expressing distinct transcriptional regulators, RORγt versus Foxp3, respectively, and the addition of IL-6 turns them into T h 17 cells (5) . This differentiation process of T h 17 cells is controlled by transcription factors which can determine lineage commitment, such as STAT3 (6) , RORγt (1), IRF4 (7), BATF (8) and HIF-1α (hypoxiainducible factor-1α) (9) . However, a role of signal modulators for these transcription factors including ubiquitin ligase and kinase still remains to be fully elucidated. Many studies used transcriptome analyses to identify the molecules that are involved in T h 17 cell differentiation. However, profiling mRNA expression of genes is not enough to understand the molecular dynamics that are not regulated at the transcription level but are regulated at the post-transcriptional level. Therefore, in addition to transcriptome analysis, we employed a large-scale cDNA library screen with a pIl17a-reporter assay system to identify molecules that play a role in the differentiation of T h 17 cells.
Using full-length cDNA library screening, we found that E3 ubiquitin ligases SIAH1 and SIAH2 functionally modulate IL-17 expression. SIAH1and SIAH2 form a family of SIAH, which is the human homolog of the Drosophila seven in absentia (sina) gene. SIAH1 and SIAH2 are RING-fingertype ubiquitin ligases with a catalytic RING domain on the N-terminus, followed by two zinc fingers and a C-terminal substrate-binding domain. SIAH1 and SIAH2 share a highly conserved C-terminal sequence and facilitate ubiquitination and proteasome-dependent degradation of multiple proteins (10, 11) . One of the most striking roles of SIAH proteins is their involvement in hypoxia signaling via regulation of the key pro-angiogenic factor, HIF-1α.
HIF-1α is classically known to be the transcription factor that mediates the metabolic switch from oxidative phosphorylation to aerobic glycolysis in response to hypoxia (12) involved in various disease pathologies including cancer and autoimmune diseases (13) . It has also recently been reported that HIF-1 promotes T h 17 differentiation by direct transcriptional activation of RORγt and subsequently collaboration with RORγt to regulate downstream IL-17 transcription (9, 14, 15) . In fact, the mice lacking HIF-1α have deregulation in the T h 17/Treg balance, resulting in the impairment of the IL-17 production and increased numbers of Foxp3 + Treg cells, resulting in acquisition of resistance to the T h 17-mediated diseases, such as experimental autoimmune encephalomyelitis.
Stabilization of HIF-1α is controlled by hydroxylation of HIF-1α by PHDs (prolyl hydroxylases) and FIH (factor inhibiting HIF-1α) (10, 16, 17) . These hydroxylases were reported to be regulated by SIAH1 and SIAH2. Degradation of PHD1/3 and FIH by SIAH1 and SIAH2, in turn, enhances protein stability of HIF-1α under hypoxic conditions (16, 18) . Under normoxic conditions, HIF-1α is always degraded after hydroxylation by PHDs and FIH, therefore its protein level is maintained very low (10, 16, 17) . However, the role of SIAH1 and SIAH2 in T cells has not been reported yet.
In this report, we identified SIAH family proteins as potential modulators that enhanced T h 17 cell differentiation by comprehensive screening using a full-length cDNA library. Our data indicated that expression of SIAHs plays a pivotal role to maintain the stability of HIF-1α protein, consequently leading to an increase of IL-17 production. This ubiquitination modulator may be required for the regulation of the T h 17/Treg balance. We discuss about an intrinsic role of ubiquitin ligases, SIAH1 and SIAH2, in protection from autoimmune situation.
Methods

Mice and cell lines
All animal experiments were conducted in accordance with the guidelines for animal experimentation administered by the Animal Care and Use Committee of the RIKEN Yokohama Institute, Keio University and Nippon Boehringer Ingelheim. C57BL/6 mice were purchased from Japan SLC (Shizuoka, Japan). T-cell-specific Hif1a-deficient mice, namely Lckcre Hif1a flox/flox (Hif1a-CKO), were described previously (15) . In brief, the Hif1a-CKO mice were generated by crossing Lck-cre and Hif1a flox/flox mice purchased from the Jackson Laboratory (Bar Harbor, ME, USA). Hif1a flox/flox mice were used as a control. The genetic background of Hif1a-CKO mice that were used in this study was C57BL/6. All mice were maintained in the specific-pathogen-free animal facilities and 6-to 10-week-old mice were used for all experiments. T-cell line 68-41 cells have been described previously (19) . HEK293FT was obtained from Invitrogen.
Plasmids
The murine Il17a promoter plasmids have been described previously (20) . In short, the Il17a promoter plasmid was generated by PCR using mouse genomic DNA as a template. A ~6 kb fragment corresponding to nucleotides from −6021 to +37 relative to the determined transcriptional staring site of the Il17a gene was sub-cloned into pGV-basic 2 vector (TOYOINKI).
The murine Il4 promoter plasmids have been described previously (19) . In short, the Il4 promoter plasmid was generated by PCR using a mouse genomic DNA fragment as a template. The 829 bp fragment corresponding to nucleotides from −766 to + 63 was sub-cloned into pGL-2 vector (Promega).
The murine Ifng promoter plasmids have been described previously (21) . In short, the Ifng promoter plasmid was generated by PCR using a mouse genomic DNA fragment as a template. The 588 bp fragment corresponding to nucleotides from −583 to + 5 was sub-cloned into pGL-2 vector (Promega).
Murine Siah1 and Siah2 cDNAs were amplified by PCR. The cDNAs were inserted into a pMX-IRES-GFP vector and pcDNA3.1 vector to generate pMX-IRES-GFP-SIAH1 (Siah1-GFP) and pMX-IRES-GFP-SIAH2 (Siah2-GFP) and pcDNA3.1/ SIAH1 and pcDNA3.1/SIAH2, respectively.
cDNA library screening
For cDNA library screening, the mouse MGC (Mammalian Gene Collection) full-length cDNA library (6344 clones) was obtained from ATCC. The clones in the library were picked up randomly without bias, and the number of the cDNA clones in the library was maximum when the screening was performed. The cDNA clones include the regions from 3′ UTR to 5′UTR of each gene. Fifty nanograms of each plasmid clone with 12 ng pCMVTa-mRORgt were spotted onto two wells of a 384-well plate (n = 2). Fifty nanograms of control (pcDNA3.1), negative control (Gfi-1) and positive control (confidential) plasmids were also spotted onto two wells of each 384-well plate (n = 2). Two nanograms of the murine Il17a promoter plasmids, pGV-basic2-mouse pIl17a (−6021 to +37) were added into each well and incubated for 15 min using FuGENE6 transfection reagent (Roche). Then 4000 HEK293FT cells were added into each well (reverse transfection). After 24 h, the luciferase activity was measured by an EnVision multiple plate reader (Perkin Elmer) after adding the Bright-Glo luciferase assay system (Promega) and incubating for 5 min. For counter screening, Ifng reporter construct, pGL2-mouse pIfng (−583 to +5), and Il4 reporter construct, pGL2-mouse pIl4 (−766 to +63), were used. One hundred and fifty nanograms of each plasmid were spotted onto a 96-well plate (n = 2). One hundred nanograms of pGL2-pIfng or pGL2-pIl4 plasmid were added into each well and incubated for 15 min using Fugene6. Then 1 × 10 4 HEK293FT cells were added into each well (reverse transfection). After 24 h, the luciferase activity was measured by EnVision after adding Bright-Glo and incubating for 5 min.
Luciferase assay
HEK293FT cells were seeded on 96-well plates (2 × 10 4 cells per well) and transfected with various amounts of expression vector with Fugene6 reagent. After transfection, HEK293FT cells were cultured with PMA plus ionomycin for 24 h. The luciferase activity was measured by an EnVision multiple plate reader (Perkin Elmer) after adding the Bright-Glo luciferase assay system and incubating for 5 min.
The 68-41 cells were seeded on 12-well plates (4.5 × 10 5 cells per well) and transfected with various amounts of expression vector by electroporation (Digital Bio) with a Neon kit (Invitrogen). After transfection, 68-41 cells were cultured for 24 h, then re-stimulated with 1 µg ml −1 plate-bound anti-CD3 antibody (clone 145-2C11) for 24 h. The luciferase activity was measured by an EnVision multiple plate reader (Perkin Elmer) after adding the Dual-Glo luciferase assay system and the firefly luciferase activity was normalized by Renilla luciferase activity.
Reagents and antibodies
Recombinant mouse IL-6 and human TGF-β1 were purchased from eBioscience and R&D Systems. Recombinant mouse IL-12p70 was obtained from eBioscience. Recombinant mouse IL-4 was obtained from Peprotech. Phycoerythrinconjugated anti-mouse IL-17A (TC11-18H10) antibody was purchased from BD Bioscience. Anti-β-actin (#4967) was purchased from Cell Signaling Technology. Anti-SIAH1 (ab2237) was purchased from Abcam. Anti-SIAH2 (sc-5507) was purchased from Santa Cruz. Anti-HIF-1α (MA1-516) was purchased from Thermo Scientific. Protein Transport Inhibitor (GolgiStop) was purchased from BD Bioscience. PMA and ionomycin were purchased from Sigma-Aldrich.
Naive T-cell preparation and differentiation
RPMI 1640 (Sigma) supplemented with 10% FCS (EquitechBio), 50 µM 2-mercaptoethanol (Gibco), 100 U ml −1 penicillin (Gibco) and 100 µg ml −1 streptomycin (Gibco) was used as a complete culture medium. CD4 + CD25 − CD62L high T cells (naive CD4 + T cells) were purified (purity: >95%) from splenocytes using a CD4 + CD62L + T-cell isolation kit II (Miltenyi Biotec). Naive CD4 + T cells were cultured in 48-well plates (2 × 10 5 cells per well) and stimulated with immobilized anti-CD3e antibody [plates coated with 5 µg ml −1 anti-CD3e antibody (eBioscience, clone 145-2C11) in 300 µl PBS] and 1 µg ml −1 soluble anti-CD28 antibody (SouthernBiotech, clone PV-1). Culture medium was supplemented with 10 ng ml −1 IL-12p70 and 10 µg ml −1 anti-IL-4 antibody (eBioscience, clone 11B11) for T h 1 differentiation; 10 ng ml −1 IL-4 and 10 µg ml −1 anti-IFN-γ antibody (eBioscience, clone AN-18) for T h 2 differentiation; 10 µg ml −1 anti-IFN-γ antibody, 10 µg ml −1 anti-IL-4 antibody and 10 ng ml −1 human TGF-β1 for Treg differentiation; and 10 µg ml −1 anti-IFN-γ antibody, 10 µg ml −1 anti-IL-4 antibody, 2 ng ml −1 recombinant human TGF-β1 and 20 ng ml −1 recombinant mouse IL-6 for T h 17 differentiation.
Retroviral transduction
CD4
+ CD25 − T cells were plated and subjected to the various T h cell differentiation conditions, starting on day 0. On day 1 and 2, fresh retrovirus supernatant was added twice. After infection, the cells were cultured in the appropriate T h cell differentiation media and harvested on day 4 or 5 for intracellular IL-17A staining, ELISA analysis and western blot analysis. The transduction efficiencies used in each retrovirus expression vector were in the range 50-80% of GFP + cells, and IL-17A expression was examined in the GFP + cells.
Flow cytometry
For intracellular cytokine staining, cells were stimulated for 4 h in complete medium with PMA (50 ng ml −1 ) and ionomycin (1 µg ml −1 ) in the presence of Protein Transport Inhibitor (GolgiStop, BD Bioscience). Surface staining was then performed in the presence of Fc-blocking antibodies (2.4G2). Intracellular staining for cytokines with the Fixation and Permeabilization kit (BD Bioscience) was performed according to the manufacturer's instructions. Data were acquired through a FACSCalibur (BD Biosciences) and were analyzed with FlowJo software (Tree Star).
Enzyme-linked immunosorbent assay
Supernatants were collected after the indicated periods of cell culture and were analyzed for IL-17A with an ELISA kit (eBioscience) according to the manufacturer's instructions.
SDS-PAGE and western blotting
Cells were washed, lysed in a Cell Lysis Buffer (Cell Signaling Technology) then added with sample buffer and boiled. Whole cell lysates were separated by SDS-PAGE and transferred to a polyvinylidene difluoride membrane (Millipore). The membrane was blocked and probed with the primary antibodies. The membrane was then washed and probed with appropriate secondary antibodies conjugated to HRP and visualized with an ECL Prime Western Blotting Detection Reagents (GE Healthcare) according to the manufacturer's instructions. β-Actin was used as a loading control. An LAS-3000 imaging system (Fuji) was used to quantitate digital images.
Quantitative RT-PCR
Total RNA was extracted using RNeasy mini kits (Qiagen). cDNA was reverse transcribed using a ReverTra Ace qPCR RT Master Mix (TOYOBO) according to the manufacturer's protocol. Quantitative RT-PCR (qRT-PCR) of cDNA from each sample was performed by using two gene-specific unlabeled primers and the KAPA SYBR green qRT-PCR assay (Kapa Biosystems) utilizing the CFX384 Real-Time PCR System (Bio-Rad Laboratories). Gapdh levels were measured in a separate reaction and used to normalize the data by the Δ − ΔC t method, using the mean cycle threshold (C t ) value for Gapdh and the gene of interest for each sample. The following primer sequences were used to detect each mRNA: mouse Siah1, sense primer, 5′-TGCCCTGGTGCTTCCTGTAA-3′, anti-sense primer, 5′-TCACCCAGTCAACAGCACCA-3′; mouse Siah2, sense
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primer, 5′-CTGTTTCCCTGTAAGTATGCTACC-3′, anti-sense primer, 5′-CACTGACAGCATGTAGATATCGTG-3′; mouse Hif1a, sense primer, 5′-AGCTTCTGTTATGAGGCTCACC-3′, anti-sense primer, 5′-TGACTTGATGTTCATCGTCCTC-3′; mouse Rorgt, sense primer, 5′-TGCAAGACTCATCG ACAAGG-3′, anti-sense primer, 5′-AGGGGATTCAACATCAG TGC-3′; mouse Il17a, sense primer, 5′-CTCCAGAAGGCCC TCAGACTAC-3′, anti-sense primer, 5′-AGCTTTCCCTCCGC ATTGACACAG-3′; mouse Gapdh, sense primer, 5′-TGTGTCCG TCGTGGATCTG-3′, anti-sense primer, 5′-TTGCTGTTGAA GTCGCAGG-3′; human Hif1a, sense primer, 5′-GCTGGCCCCA GCCGCTGGAG-3′, anti-sense primer, 5′-GAGTGCAGGG TCAGCACTAC-3′; and human GAPDH, sense primer, 5′-GCACCGTCAAGGCTGAGAAC-3′, anti-sense primer, 5′-TGGTGAAGACGCCAGTGGA-3′.
siRNA introduction
Either of a siRNA (Qiagen) for the gene of interest (25 nM) or AllStars Negative Control siRNA (Qiagen) (25 nM) was transfected into HEK293FT cells using HiPerFect Transfection Reagent (Qiagen) according to the manufacturer's instructions.
Statistics
Mean values and SEs of the mean values were calculated from at least three independent experiments. P values indicated in each graph were calculated using a two-tailed unpaired Student's t-test.
Results
Identification of SIAH1 in the cDNA library screening as a modulator for IL-17A promoter activity
We carried out random screening of the Il17a promoter reporter in the HEK293FT cells that expressed an individual clone of the MGC full-length cDNA library (6344 clones) (Fig. 1A) and searched the genes that activated the reporter activity in the presence or absence of Rorγt. Combined with expression profiles on the GEO public data base (accession number: GSE14308), we selected 141 candidate genes that satisfied the following two criteria: (i) the genes that exhibited 3-fold higher luciferase activity compared to control plasmid (pcDNA3.1) or (ii) the genes that showed not only 1.5-fold higher luciferase activity than control but also the expression value of T h 17 cells in GEO database that exceeded 2-fold higher than the value of T h 2 cells. We further narrowed down up to eight genes on the basis of information including drug probability, phenotype of genetically engineered mice and genomics databases (22) . We further carried out counter screening with the Il4 and Ifng promoter assay (Fig. 1B) , and then we identified the E3 ubiquitin ligase SIAH1 as a positive regulator for the Il17a promoter from the random screening.
SIAH1 and SIAH2 increased expression of RORgt and IL-17A
SIAH2 is another SIAH family member, which is structurally related to SIAH1. We found that over-expression of SIAH2 similarly enhanced the Il17a promoter activity in the HEK293FT cells (Fig. 1C) . The positive regulation for the Il17a promoter by SIAH1 and SIAH2 was also found in the mouse T-cell hybridoma 68-41 ( Fig. 2A) . Furthermore, over-expression of either SIAH1 or SIAH2 increased mRNA expression of Il17a as well as Rorgt in 68-41 cells (Fig. 2B) . On the other hand, both SIAH1 and SIAH2 had no effect on the Il4 and Ifng promoter. These results suggested that SIAH1 and SIAH2 both played roles as specific regulators for Il17 transcription.
SIAH1 and SIAH2 expression among T h cell subsets
We next investigated whether the protein expression patterns of SIAH1and SIAH2 among T h cell subsets associate with the expression profile of HIF-1α that is selectively expressed in T h 17 cells. Though SIAH1 protein was relatively highly expressed in naive CD4 + T cells, both SIAH1 and SIAH2 proteins were most highly expressed in T h 17 cells, which is well associated with HIF-1α protein expression (Fig. 3A) . On the basis of the time-dependent mRNA expression profiles, the induction of Siah2 was more prominent than Siah1 and was tightly associated with kinetics of the Hif1a mRNA expression in T h 17 cells (Fig. 3B) . Because SIAH2 expression was higher in T h 17 cells than in Treg cells and increased according to T h 17 cell differentiation, signals from IL-6 may regulate SIAH2 expression. These data suggested that SIAH2 expression well associated with the expression profile of HIF-1α during the differentiation process of T h 17 cells.
Expression of SIAH1 and SIAH2 in CD4 + T cells enhanced T h 17 differentiation
We next ask whether the preferential expression of SIAH1 and SIAH2 reflected on the T h 17 development in mouse primary CD4 + T cells. Retroviral transduction of SIAH1 and SIAH2 into CD4 + T cells was carried out under T h 17 skewing conditions with or without suboptimal doses (0.1, 0.3 ng ml −1 ) of IL-6 (Fig. 4A) . Both SIAH1 and SIAH2 induced small numbers of T h 17 cell even in the absence of IL-6, and more T h 17 cells were induced along with an increased concentration of IL-6. The induction of T h 17 cell differentiation was more prominent in SIAH2 than SIAH1. This was confirmed with the IL-17 protein concentrations secreted in the culture supernatant from the re-stimulated CD4 + T cells (Fig. 4B) . These results demonstrated that both SIAH1 and SIAH2 had a potential to promote T h 17 cell differentiation in CD4 + T cells.
SIAH1 and SIAH2 promoted the T h 17 cell differentiation in a HIF-1α-dependent manner
SIAH1 and SIAH2 are reported to be ubiquitin ligases that control stability of HIF-1α protein (18) . HIF-1α, in turn, controls Il17a transcription as a transcriptional activator of RORγt or as a co-activator with RORγt (9, 14) . Therefore, we hypothesized that SIAH1 and SIAH2 work as a positive regulator for Il17a expression via controlling the protein stability of HIF-1α. Thus, we next investigated the effect of over-expression of SIAH1 or SIAH2 on the protein levels of HIF-1α in the SIAH1 or SIAH2 transduced CD4 + T cells and T-cell line, 68-41. SIAH1 and SIAH2 clearly increased the protein expression of HIF-1α not only in CD4 + T cells but also in 68-41 cells ( Fig. 4C and D) . Consistent with the result observed in IL-17 expression, SIAH2 had a higher potential to stabilize HIF-1α protein rather than SIAH1. We speculated that SIAH induced T h 17 differentiation was due to the increased protein stability of HIF-1α, and SIAH2 seems to have a more prominent role in T h 17 differentiation.
If SIAHs function is HIF-1 mediated, SIAH over-expression should not be effective on the IL-17 expression in the absence of HIF-1α protein. To study this possibility, HEK293FT cells were treated with siRNA specific for HIF1a and the IL-17A promoter activity was examined after transfection with either Siah1 or Siah2 cDNA. As shown in Fig. 5A , the siRNA treatment almost completely repressed the expression of HIF1a mRNA. Under these circumstances, HIF1a siRNA clearly attenuated the Il17a promoter activity that was induced by over-expression of Siah1/2 (Fig. 5B,  left) . Furthermore, the Rorγt-mediated promoter activation was also diminished by treatment with siRNA specific for HIF1a (Fig. 5B, right) . These results indicated that the gain of function of SIAH1 and SIAH2 required the expression of HIF-1α protein. In addition, our results suggested that HIF-1α regulated the IL-17A expression through the induction of RORγt expression. 
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Next we explored whether this also happens in primary CD4 T cells, and further asked whether the enhanced effect of SIAH1/2 is a consequence of transcriptional activation mediated by HIF-1α. Either SIAH1 or SIAH2 were retrovirally introduced into the CD4 + T cells obtained from T-cell-specific Hif1a-deficient mice (Hif1a-CKO) and wild-type control mice (Fig. 5C ). The percentage of the IL-17 + T cells in Hif1a-CKO mice is significantly lower than that in control mice, and the gain of function by SIAH1/2 was not found in T cells lacking Hif1a. Taken together, these data supported our hypothesis that SIAH1/2 promoted T h 17 cell differentiation through the control of protein stability of HIF-1α.
Discussion
Many studies have been accumulated to understand the molecular basis that controls the expression of IL-17 during T h 17 differentiation. Transcriptome analysis is the major approach taken to identify novel molecules or new signaling pathways. However, although profiling mRNA expression of genes is useful to identify the molecules regulated at the transcription level, this technique is not appropriate enough to understand the molecular dynamics that are regulated by post-transcriptional regulation. Therefore, it still remains unclear how the gene expression profile is initiated and maintained during the differentiation process of T h 17 cells. To overcome this issue, a large-scale cDNA library screen was applied, then the result was integrated with expression data from GEO (GSE14308) and evaluated with information from various databases. This approach seemed to be efficient to identify both molecules regulated at the transcription level and those regulated at the post-transcriptional level. The probable efficacy of this approach was proved by the finding that posttranscriptional regulation by E3 ubiquitin ligases SIAH1 and SIAH2 plays a role in IL-17A production. ZNFN1A3, TORC2, TCF7, SP2, SLAMF7, RGS3 and POU2AF1 showed better or equivalent efficiency rather than SIAH1 in our initial screening (Fig. 1B) . However, our promoter analysis indicated that ZNFN1A3, TORC2, TCF7, SP2, RGS3 and POU2AF1 were also effective for the IL-4 and/or interferon promoter activities. Moreover, ZNFN1A3 and POU2AF1 have been demonstrated to play a critical role in T h 17 differentiation though the inhibition of IL-2 expression (23, 24) . Interestingly, POU2AF1 was reported to be regulated by SIAH1 and SIAH2 in B cell (25, 26) . TORC2 (also called CRTC2) has been shown to promote T h 17 differentiation (27) . SP2 has been reported to maintain T h 17 function through maintaining expression of RORγT in vitro (28) . This evidence strongly supports the reliability of the assay system that we used in the present study. TCF7 has been reported to be an important transcriptional factor regulating T follicular helper cell differentiation via the control of IL-6 sensitivity (29-31). After additional consideration based on the public and reference-based information, including drug probability, mouse phenotype in reverse genetics and genomics databases, we chose SIAH1 as the unknown candidate factor to possibly control IL-17 expression.
Since SIAH1/2 activate the IL-17A promoter without affecting IFN-γ and IL-4 promoters, we hypothesized that SIAH1/2 may activate the IL-17A promoter in T h 17 skewing condition. The specificity of SIAH1 and SIAH2 on T h 17 cells was also found in the protein expression between T h cell subsets. SIAH1 and SIAH2 proteins were most highly expressed in T h 17 cells, which is well associated with HIF-1α protein expression. An important issue we need to further discuss is which of SIAH1 or SIAH2 is more effective. We found that SIAH2 mRNA expression kinetics in T h 17 skewing condition are well associated with HIF-1α and IL-17A mRNA expression. IL-6 seems to be responsible for SIAH2 protein because SIAH2 expression was higher in T h 17 cells than in Treg cells. It is likely that IL-6 may positively regulate not only Siah2 expression but also possibly SIAH protein function by phosphorylation or autoubiquitination (32) (33) (34) . On the other hand, SIAH1 was constitutively expressed in naive CD4 + T cells, and its expression was maintained during T h 17 differentiation. As several reports suggested that SIAH1 and SIAH2 have overlapping functions and possibly work in a mutually complementary manner (10), we considered that SIAH1 may function in the early stage of T h 17 differentiation and SIAH2 SIAH1 and SIAH2 have been reported to enhance HIF-1α protein stability by the degradation of PHDs and FIH (16, 18, 35) . Indeed, the expression of SIAH1/2 increased protein expression of HIF-1α. Therefore, we assumed that expression of SIAH1/2 under T h 17 skewing conditions stabilized HIF-1α via degradation of PHDs and FIH though further studies will be required to confirm this.
Dang et al. (9) showed that IL-6 up-regulates protein expression of HIF-1α in a STAT3-dependent manner, leading to transactivation of RORγt and subsequently HIF-1α/RORγt/ p300-mediated activation of IL-17. As discussed above, the presence of IL-6 in T h 17 differentiation may induce Siah2 mRNA expression and also modify the phosphorylation or ubiquitination status of SIAH protein and subsequently stabilize HIF-1α protein. However, we need further studies to reveal how the IL-6 pathway up-regulates HIF-1α through SIAH proteins. Similar to Dang et al. (9) , another study from Shi et al. (14) on HIF-1α suggested that HIF-1α is involved in T h 17 differentiation but ascribed the role of HIF-1α to upregulation of glycolysis and not to a direct effect of HIF-1α on RORγt. Moreover, Shi et al. (14) suggested the HIF-1α-dependent glycolytic pathway is downstream of mTOR signaling, thereby contributing to mTOR-mediated T-cell differentiation. Ikejiri et al. (15) showed that a positive feedback loop between HIF-1α and mTORC1 induced by hypoxia followed by reoxygenation accelerates T h 17 differentiation. We have added to these by showing that SIAH1 and SIAH2 are deeply involved in the regulation of HIF-1α, elucidating a 
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novel regulatory mechanism of HIF-1α in T h 17 cells (Fig. 6) . Further studies will be required to remove the discrepancy between studies. Nevertheless, many studies have demonstrated that inflammatory environments are relatively hypoxic and it is clear that an increase in local inflammation triggers a decrease in oxygen concentration, leading to stabilization of HIF-1α that would possibly amplify the whole cascade. It is therefore speculated that HIF-1α stability, which can be regulated by SIAH1/2, represents a mechanism by which the hypoxic conditions associated with inflammation can promote T h 17 differentiation.
On the other hand, other pathways that Siah1 may be involved in, which is, the β-catenin transmitting pathways should be considered, because it is reported that Siah-1 down-regulates β-catenin signaling by interacting with the carboxyl terminus of adenomatous polyposis coli and promoting degradation of β-catenin in mammalian cells (36) . In addition, several reports indicated that Wnt/β-catenin negatively regulates T h 17 development (37-39). Therefore, it was reasonable that SIAH1 may activate IL-17 production by reducing the β-catenin level. However, in our system, we did not observe the effect of SIAH1 on β-catenin protein expression (data not shown), therefore we assumed that the effect of SIAHs on β-catenin pathways for IL-17 production is limited.
In conclusion, we have demonstrated that SIAHs are the positive regulators on T h 17 differentiation by maintaining Fig. 5 . SIAH1 and SIAH2 promote T h 17 cell differentiation in a HIF-1α-dependent manner. (A) 293FT cells were transfected with HIF1a-specific siRNA (siHIF1a) or negative control siRNA (siNega). Forty-eight hours after transfection, cells were harvested for preparation of total RNA and HIF1a mRNA was detected by qRT-PCR. Data are normalized to GAPDH mRNA copy number and the mean and SEM (n = 3) are indicated. (B) 293FT cells were transfected with HIF1a-specific siRNA (siHIF1a) or negative control siRNA (siNega). Forty-eight hours after transfection, cells were harvested and transfected with pIl17a-reporter and plasmid of Siah1, Siah2, Rorgt or pcDNA3.1 (control) with stimulation with PMA and ionomycin. Sixteen hours after transfection, luciferase activity was measured. Data represent three independent experiments. Error bars are SD. *P < 0.05. (C) SIAH1 and SIAH2 increase the IL-17 producing cell proportion in a HIF-1α-dependent manner in mouse primary CD4 + T cells. T-cell-specific Hif1a -deficient mice (Hif1a -CKO) and C57/BL6 wild-type mice (control) were used to prepare CD4 + T cells. Then they were activated with anti-CD3 antibody and anti-CD28 antibody under T h 17 skewing conditions with 0.3 ng ml −1 of IL-6 and were transduced with either a retrovirus expressing S Siah1-GFP (SIAH1), Siah2-GFP (SIAH2) or GFP containing empty vector (Control). On day 5, cells were harvested and intracellular IL-17A was stained and analyzed by FACS. The panels show the FACS analysis data for both Hif1a-CKO and wildtype mice. Numbers represent the percentage of IL-17 + cells in GFP + cells. Data are representative of two separate experiments (n = 4, in total).
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HIF-1α stability, which is the novel regulatory mechanism for IL-17 production through the SIAH1/2-HIF-1α-Rorγt-IL-17A axis. Therefore, SIAH proteins could be therapeutic targets for amelioration of autoimmune diseases pathogenesis. 
